Articles can be viewed by the current month and the archive. If nothing appears on the page, then please select the archive option on the left.
Click here to receive the latest Cardiovascular News in RSS formatCRP predicts cardiac morbidity, mortality after angioplasty
Baseline levels of C-reactive protein in patients undergoing percutaneous coronary intervention predict clinical outcomes 1 year later, a pooled analysis of clinical trial data suggests.
7 January 2009
Baseline levels of C-reactive protein in patients undergoing percutaneous coronary intervention predict clinical outcomes 1 year later, a pooled analysis of clinical trial data suggests.
Being overweight, inactive increases heart failure risk in men
Being overweight, inactive increases heart failure risk in men
Overweight and obese men are more likely to develop heart failure than their leaner counterparts, say researchers who also found that regular vigorous physical activity may reduce this risk.
6 January 2009
Overweight and obese men are more likely to develop heart failure than their leaner counterparts, say researchers who also found that regular vigorous physical activity may reduce this risk.
Diabetes in men increases CV mortality three-to-four fold
Men with isolated Type 2 diabetes have a three-to-four-fold increased risk for cardiovascular mortality compared with their nondiabetic counterparts, Canadian scientists have shown.
6 January 2009
Men with isolated Type 2 diabetes have a three-to-four-fold increased risk for cardiovascular mortality compared with their nondiabetic counterparts, Canadian scientists have shown.
Antihypertrophic mechanism of PDE5 inhibitors elucidated
The regulator of G-protein signaling 2 pathway plays a major role in the heart, offering protection against hypertrophy and dysfunction in the early stages of pressure overload, new research demonstrates.
6 January 2009
The regulator of G-protein signaling 2 pathway plays a major role in the heart, offering protection against hypertrophy and dysfunction in the early stages of pressure overload, new research demonstrates.
Stent diameter influences risks, benefits of DES versus BMS
Stent size may influence the rate of clinical events associated with drug-eluting devices and should be considered in the risk–benefit equation, clinical data suggest.
5 January 2009
Stent size may influence the rate of clinical events associated with drug-eluting devices and should be considered in the risk–benefit equation, clinical data suggest.
Neuropeptide Y is strong candidate gene for early CAD
A functional variant of the gene encoding neuropeptide Y is strongly associated with early-onset coronary artery disease, a US team has shown.
5 January 2009
A functional variant of the gene encoding neuropeptide Y is strongly associated with early-onset coronary artery disease, a US team has shown.
